Found 13 matching trials
Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer NA RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, fluorouracil, a...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC PHASE2 This phase II randomized trial evaluates PD-1 inhibitor plus chemotherapy f...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA PHASE2 Primary brain tumors are typically treated by surgery, radiation therapy an...
Show More Location
Lenox Hill Brain Tumor Center
Learn More & Join Trial
Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies NA The purpose of this study is to compare the results of positron emission to...
Show More Location
Cleveland Clinic, Case Comprehensive Cancer Center
Learn More & Join Trial
TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma PHASE3 Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma NA The objective of this clinical trial is to compare the effects of yttrium-9...
Show More Location
The First Affiliated Hospital of Jinan University
Learn More & Join Trial
Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck PHASE1 This is an open-label, non-randomized, two arm, Phase I research study of s...
Show More Location
Lenox Hill Hospital
Learn More & Join Trial
Short RT Versus RCT,Followed by Chemo and Organ Preservation for Interm and High-risk Rectal Cancer Patients PHASE3 The hereby proposed ACO/ARO/AIO-18.1 randomized trial aims to directly comp...
Show More Status
Active Not Recruiting
Location
Clincal Center Esslingen
Treatments Being Tested
Oxaliplatin, 85 mg/m2 5FU; 2400 mg/m2 5FU, 250 mg/m2 5FU, 2400 mg/m2 Oxaliplatin 50 mg/m2 Folinic Acid, 400 mg/m2 Radiotherapy control, 5x5 Gy: 25 Gy Capecitabine, 1000 mg/m2 Oxaliplatin 85 mg/m2 radiotherapy experimental, 30 x 1,8 Gy: 54 Gy Capecitabine, 825 mg/m2 Oxaliplatin, 130 mg/m2 Learn More & Join Trial
Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer PHASE2 RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor ...
Show More Learn More & Join Trial
Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer PHASE2 RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. S...
Show More Location
Emory Crawford Long Hospital
Learn More & Join Trial